University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Role of Positive Affect in Adjustment to HIV

Completed

Conditions: HIV Infections

First Posted Date: 2007-12-28

Last Posted Date: 2013-11-25

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 160

Registration Number: NCT00582023

Locations: 🇺🇸
Osher Center for Integrative Medicine, UCSF, San Francisco, California, United States

Study to Evaluate the Natural History of Osteoporosis in Children and Adolescents With Systemic Lupus Erythematosus

Completed

Conditions: Lupus Erythematosus, Systemic

First Posted Date: 2007-12-28

Last Posted Date: 2020-04-01

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 243

Registration Number: NCT00582465

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Long-Term Outcome of Children and Adolescents With Anti-Phospholipid Antibodies

Completed

Conditions: Lupus

First Posted Date: 2007-12-28

Last Posted Date: 2024-12-27

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 110

Registration Number: NCT00581763

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Biomarker Study for Heart Failure in Children With Single Ventricle Physiology

Completed

Conditions: Unbalanced AV Canal
Tricuspid Atresia
Hypoplastic Left Heart Syndrome

First Posted Date: 2007-12-11

Last Posted Date: 2015-05-14

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 71

Registration Number: NCT00571233

Locations: 🇺🇸
Pediatric Heart Center, University of California, San Francisco, San Francisco, California, United States

Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer

Phase 1

Completed

Conditions: Fungal Keratitis

Interventions: Drug: Voriconazole
Drug: Natamycin 5%
Procedure: Corneal de-epithelialization

First Posted Date: 2007-11-14

Last Posted Date: 2018-08-07

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 120

Registration Number: NCT00557362

Locations: 🇮🇳
Aravind Eye Hospital, Pondicherry, Tamil Nadu, India

Effect of Cocoa Flavanols on Vascular Function

Phase 1

Completed

Conditions: Coronary Artery Disease

Interventions: Other: Placebo
Dietary Supplement: Cocoa Flavanols

First Posted Date: 2007-11-06

Last Posted Date: 2016-10-27

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 16

Registration Number: NCT00553774

Locations: 🇺🇸
University of California, San Francisco, California, United States

Epilepsy Phenome/Genome Project

Completed

Conditions: Lennox-Gastaut Syndrome
Periventricular Heterotopias
Polymicrogyria
Epilepsy
Localization-related Epilepsy
Infantile Spasms

First Posted Date: 2007-11-01

Last Posted Date: 2018-11-13

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 4150

Registration Number: NCT00552045

Locations: 🇺🇸
Children's Hospital Boston, 300 Longwood Ave., Boston, Massachusetts, United States
🇺🇸
University of Alabama at Birmingham, Epilepsy Center, 1719 6th Ave S, CIRC, Ste 312, Birmingham, Alabama, United States
🇺🇸
Mayo Clinic College of Medicine, 200 First St., SW, Rochester, Minnesota, United States

and more 22 locations

Paleolithic Diets vs T2D and Improvements in the Metabolic Syndrome

Not Applicable

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Other: Paleolithic diet
Other: ADA ( American Diabetes Association) recommended diet

First Posted Date: 2007-10-24

Last Posted Date: 2020-02-28

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 22

Registration Number: NCT00548782

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia

Phase 4

Completed

Conditions: Frontal Lobe Dementia
Frontotemporal Lobe Dementia
Semantic Dementia

Interventions: Drug: memantine
Drug: Placebo pill

First Posted Date: 2007-10-18

Last Posted Date: 2020-11-17

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 81

Registration Number: NCT00545974

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
University Hospitals of Cleveland / Case Medical Center, Cleveland, Ohio, United States

and more 6 locations

Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2

Phase 1

Completed

Conditions: Breast Cancer
Metastatic Cancer

Interventions: Drug: lapatinib ditosylate
Genetic: gene expression analysis
Other: diagnostic laboratory biomarker analysis

First Posted Date: 2007-10-16

Last Posted Date: 2014-07-02

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 41

Registration Number: NCT00544804

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy